Drug interactions
Eslicarbazepine + Zanubrutinib
Severity: Major
Eslicarbazepine and Zanubrutinib: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Zanubrutinib is a CYP3A4 substrate, and moderate inducers reduce its exposure. Lower levels may compromise control of the B-cell malignancy.
What this interaction means in plain words
Eslicarbazepine and Zanubrutinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Eslicarbazepine belongs to Central Nervous System; Zanubrutinib belongs to Oncology.
Why it happens
Eslicarbazepine induces CYP3A4, increasing zanubrutinib metabolism.
What to do
Prefer a non-inducing antiseizure drug. If unavoidable, follow labeled zanubrutinib dose increase and monitor disease response.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Zanubrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Eslicarbazepine
- Eslicarbazepine + Mavacamten Contraindicated
- Eslicarbazepine + Rilpivirine Contraindicated
- Artemether / lumefantrine + Eslicarbazepine Major
- Avapritinib + Eslicarbazepine Major
- Bedaquiline + Eslicarbazepine Major
- Benzhydrocodone / acetaminophen + Eslicarbazepine Major
Other interactions of Zanubrutinib
Frequently asked questions
Can I take Eslicarbazepine with Zanubrutinib?
MediHelp rates the interaction as major. Eslicarbazepine and Zanubrutinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Zanubrutinib is a CYP3A4 substrate, and moderate inducers reduce its exposure. Lower levels may compromise control of the B-cell malignancy.
How serious is the interaction between Eslicarbazepine and Zanubrutinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing antiseizure drug. If unavoidable, follow labeled zanubrutinib dose increase and monitor disease response.
What other medicines interact with Eslicarbazepine?
MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
